Showing results (821-830 of 866) with videos related to
Sort By:
Pageof 87
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2018
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trialsM J Maurer, T M Habermann, Q Shi, et al.ESMO Open|March 22, 2024
Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGEE Cartwright, S Slater, C Saffery, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trialM Gleeson, N Counsell, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2005
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancerG Chong, A Bhatnagar, D Cunningham, et al.Journal of Neurosurgery|April 3, 2026
The role of the blink reflex in predicting facial nerve outcomes following vestibular schwannoma surgery: a 4-year retrospective reviewJihad Abdelgadir, Tanner J Zachem, Syed M Adil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research CouncilM T Seymour, M L Slevin, D J Kerr, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2015
Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trialF Sclafani, I Chau, D Cunningham, et al.British Journal of Cancer|April 20, 2006
Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trialsI Chau, D Cunningham, C Russell, et al.Journal of the American Chemical Society|August 2, 2025
Control of Indodicarbocyanine Dimer Geometry Using Variable-Length Linkers to DNA ScaffoldsAdam A Meares, Sara R Ansteatt, Sebastián A Díaz, et al.Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|January 12, 2024
Association Between Maternal Depression and Lower Urinary Tract Symptoms in Their Primary School-Age Daughters: A Birth Cohort StudyShayna D Cunningham, Sarah Lindberg, Carol Joinson, et al.Pageof 87